Matrixyl
Also known as: Palmitoyl Pentapeptide-4
Overview
A palmitoylated pentapeptide with reasonable evidence for stimulating collagen synthesis in topical formulation.
Matrixyl is classified as a cosmetic matrikine. Its current development status is: cosmetic use. Human trial data exists but is limited in size, duration or independence; conclusions should be held loosely.
The Peptide Institute tracks Matrixyl because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Matrixyl
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 1
- Samples
- 1
- Updated
- Jul 3, 2026
- 1 Research Peptides Co. Exceptional Institute
Top Rated Matrixyl98.4% average purity across 1 sample
Purity & Testing 98 Transparency 84 Samples 1 90 View company
Research & Studies
Studies library-
Long-term outcomes with Matrixyl: an open-label extension
Reports findings relevant to the primary claims made for Matrixyl; sample size limits how far the result generalises.
-
Comparative effects of Matrixyl on metabolic endpoints
Characterises Matrixyl activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.
Independent Testing
Testing databaseLaboratory verification of Matrixyl products across the companies we index.
Community Discussions
ForumThe Peptide Institute Weekly
Research. Testing. Regulation. No hype.
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
- New research, summarized in plain English
- Independent lab results as they publish
- Score and ranking movements
